ENGLEWOOD CLIFFS, NJ, Oct. 26, 2022 (GLOBE NEWSWIRE) — Silo Pharma, Inc. (Nasdaq: SILO) (“the Company”), a developmental stage biopharmaceutical company focused on merging traditional therapeutics with psychedelic research, today announced that James Kuo, M.D. M.B.A, Vice President of R&D, will speak as a panelist at Wonderland: Miami, the largest business gathering in the psychedelic medicine…


Previous articleFree Webinar — Traditional and Modern Perspectives on Healing
Next articleMINDCURE Announces Financial Results for the First Quarter of Fiscal 2023USA – EnglishUSA – English